In vivo, in vitro, in silico:
Why computer modelling is the next evolution of the healthcare sector

 

04th September 2018, 15:00-17:00

Room PHS 5B001, European Parliament, Brussels

 

 

15.00 – 15:10

Introduction by Chairs

Lieve Wierinck, Member of the European Parliament (ALDE, Belgium)

15:10 – 15:40

In silico medicine and the Avicenna Alliance: Making Medicine Modern

Thierry Marchal, Secretary General, Avicenna Alliance

Michael Hill, VP Science, Technology and Clinical Affairs, Medtronic

Geena Malhotra, Global Head of Integrated Product Development, Cipla

15:40 – 15:50

V&V40 EU – Verification and Validation in CM&S of Medical Devices

Tina M. Morrison, Deputy Director, Division of Applied Mechanics and Chair of Modeling and Simulation Working Group, FDA

15:50 – 16:15

Feedback and questions from Participants

Dr. Adriano Henney, Chairman of the Board, Avicenna Alliance

16:15 – 16:25

CM&S and medicinal products’ lifecycle

Dr. Ingrid Klingmann, European Forum for Good Clinical Practice

16:25 – 16:50

Feedback and questions from Participants

Dr. Adriano Henney, Chairman of the Board, Avicenna Alliance

16:50 – 17:00

Closing remarks and next steps by Co-Chairs

Lieve Wierinck, Member of the European Parliament (ALDE, Belgium)

17:00 – 18:00

Networking reception and Q&A with speakers

Avicenna Alliance news

Commission participates  to international In Silico Toxicology Protocol initiative

The European Commission’s Joint Research Center (JRC) Directorate published on 22 November an article highlighting...

find out more ›

Health Tech Industry roundtable meeting discussed EU Digital Health Agenda

On 15 October, a high-level roundtable meeting, organised by European Commissioner for Digital Economy and Society Mariya...

find out more ›

EU invests €1 billion in world-class European supercomputers

The Competitiveness Council (Council of Ministers) of the European Union adopted a Regulation to establish a Joint Undertaking of European...

find out more ›

Show all activites